Production and characteristics of an infusible oxygen-carrying fluid based on hemoglobin intramolecularly cross-linked with sebacic acid

被引:43
作者
Bucci, E
Razynska, A
Kwansa, H
MathesonUrbaitis, B
OHearne, M
Ulatowski, JA
Koehler, RC
机构
[1] UNIV MARYLAND,SCH DENT,DEPT PHYSIOL,COLLEGE PK,MD 20742
[2] JOHNS HOPKINS UNIV,SCH MED,DEPT ANESTHESIOL & CRIT CARE MED,BALTIMORE,MD 21218
来源
JOURNAL OF LABORATORY AND CLINICAL MEDICINE | 1996年 / 128卷 / 02期
关键词
D O I
10.1016/S0022-2143(96)90006-2
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Research on red cell substitutes requires the availability of oxygen-carrying fluids for physiologic experiments. This article describes the procedure for in-house production of such a fluid. It coniains a hemoglobin-based oxygen carrier obtained by reacting human hemoglobin with bis-(3,5-dibromosalicyl) sebacate. This reagent produces intramolecular cross-links between the beta 82 lysines and between the alpha 99 lysines, respectively. The oxygen half-saturation pressure (P-50) of the fluid is near 34 mm Hg at 37 degrees C, with a Hill's parameter of n=2.2. The half-time of intravascular retention is near 3.0 hours in the rat and 6.5 hours in the cat. Spectrophotometric analyses of arterial and venous plasma from an infused rat reveal an efficient oxygen delivery to the tissues by the oxygen carrier. Therefore, this new cross-linked human hemoglobin can be produced in quantities sufficient for in vivo evaluation and with an oxygen affinity and cooperativity adequate for oxygen unloading in plasma.
引用
收藏
页码:146 / 153
页数:8
相关论文
共 12 条
[1]   Positive and negative cooperativities at subsequent steps of oxygenation regulate the allosteric behavior of multistate sebacylhemoglobin [J].
Bucci, E ;
Razynska, A ;
Kwansa, H ;
Gryczynski, Z ;
Collins, JH ;
Fronticelli, C ;
Unger, R ;
Braxenthaler, M ;
Moult, J ;
Ji, XH ;
Gilliland, G .
BIOCHEMISTRY, 1996, 35 (11) :3418-3425
[2]  
CHATTERJEE R, 1986, J BIOL CHEM, V261, P9929
[3]   IMMOBILIZED HEMOGLOBIN IN THE PURIFICATION OF HEMOGLOBIN-BASED OXYGEN CARRIERS [J].
CHIANCONE, E ;
FRONTICELLI, C ;
GATTONI, M ;
URBAITIS, BK ;
BUCCI, E .
JOURNAL OF CHROMATOGRAPHY, 1992, 604 (01) :117-123
[4]  
FARMER M, 1992, BIOMAT ARTIF CELL IM, V20, P429
[5]  
HESS JS, 1988, S OXYG BIND PROT STR
[6]   PHARMACOKINETIC STUDIES IN THE RAT ON A O-RAFFINOSE POLYMERIZED HUMAN HEMOGLOBIN [J].
HSIA, JC ;
SONG, DL ;
WONG, LTL ;
KEIPERT, PE ;
GOMEZ, CL ;
GONZALES, A ;
MACDONALD, VW ;
HESS, JR ;
WINSLOW, RM .
BIOMATERIALS ARTIFICIAL CELLS AND IMMOBILIZATION BIOTECHNOLOGY, 1992, 20 (2-4) :587-595
[7]  
KEIPERT PE, 1992, BIOMAT ARTIF CELL IM, V20, P737
[8]   Regional blood flow alterations after bovine fumaryl beta beta-crosslinked hemoglobin transfusion and nitric oxide synthase inhibition [J].
Ulatowski, JA ;
Nishikawa, T ;
MathesonUrbaitis, B ;
Bucci, E ;
Traystman, RJ ;
Koehler, RC .
CRITICAL CARE MEDICINE, 1996, 24 (04) :558-565
[9]  
ULATOWSKI JA, 1995, BIOMAT ARTIF CELLS S, V23, P263
[10]  
URBAITIS BK, 1991, J LAB CLIN MED, V117, P115